Abramson Cancer Center at Penn Medicine: all 457 studies

Page 3 of 5. Open to participants first (84), then studies with results posted, then the rest; newest registration first within each.

• Physical Activity in Rectal Cancer SurvivorsCompletedNCT06435975Not applicable
• Pre-Transplant INCBB099280 for Hepatocellular Carcinoma (HCC)WithdrawnNCT06337162Phase 1
• Effects of Immune Checkpoint Inhibitors on Coronary MicrovasculatureActive, not recruitingNCT06332131
• Social Media Anti-Vaping Messages to Reduce ENDS Use Among Sexual and Gender Minority TeensCompletedNCT06308081Not applicable
• Comparison of Apixaban Versus EnoxaparinCompletedNCT06243510Not applicable
• Lipiodol Deposition Using Endhole vs. Pressure-Modulated DeliveryActive, not recruitingNCT06204159Not applicable
• Penn Medicine Biobank Return of Results ProgramActive, not recruitingNCT06089954Not applicable
• Project Looking-Glass EvaluationActive, not recruitingNCT06056063Not applicable
• Early Point-of-Service Social and Behavioral Determinants of Health (SBDOH) Screening and Enhanced Navigation on Care Delivery for Patients With Breast CancerActive, not recruitingNCT06019988Not applicable
• Project PLUS Lung Cancer Screening PromotionCompletedNCT05937399Not applicable
• Staying Healthy With Follow-up Care: A Mobile Chatbot Feasibility Study for AYA Cancer SurvivorsCompletedNCT05863702Not applicable
• Increasing Adherence to Lung Cancer ScreeningCompletedNCT05832008Not applicable
• Sequential EHR Based Interventions to Increase Genetic Testing for Breast and Ovarian Cancer PredispositionCompletedNCT05721326Not applicable
• Shortened Course Adjuvant Radiotherapy Following TORSActive, not recruitingNCT05714657Phase 2
• Behavioral Economic Approaches for Population-Based Colorectal Cancer ScreeningActive, not recruitingNCT05693649Not applicable
• Assessing the Impact of a Financial Navigation Program for Patients With Multiple MyelomaCompletedNCT05448196Not applicable
• eHealth Delivery Alternative for Cancer Genetic Testing for Hereditary CancerActive, not recruitingNCT05427240Not applicable
• Preliminary Investigation of β-hydroxybutyrate Supplementation in Colorectal Cancer PreventionActive, not recruitingNCT05338307Not applicable
• Understanding Quality of Life Among Patients With Cancer Receiving Palliative CareActive, not recruitingNCT05331625Not applicable
• ChatBot and Activity Monitoring in Patients Undergoing ChemoradiotherapyActive, not recruitingNCT05318027Phase 2
• XmAb20717 in Advanced Biliary Tract CancersCompletedNCT05297903Phase 2
• Zr89 + PET Companion TrialActive, not recruitingNCT05279027Early Phase 1
• The Association Between CBT-I Dose, Sleep Duration, and Fatigue in Breast Cancer PatientsActive, not recruitingNCT05226078Not applicable
• Comparing Two Ways to Manage Head and Neck LymphedemaActive, not recruitingNCT05182229Not applicable
• RCT of Strategies to Augment Physical Activity in Black and Hispanic Breast and Prostate Cancer Survivors (ALLSTAR)CompletedNCT05176756Not applicable
• 'Penny', a SMS Text-based Chatbot Intervention for Medication Adherence and Side Effect Management Among Patients With GI CancersCompletedNCT05113264Not applicable
• Mechanisms, Predictors, and Social Determinants of Cardiotoxicity in Prostate CancerActive, not recruitingNCT05096338
• Breast Cancer Outreach Among Primary Care PatientsCompletedNCT05089903Not applicable
• Mechanisms, Predictors, and Social Determinants of Cardiotoxicity in Breast CancerActive, not recruitingNCT05078190
• Endodontic-Restorative Pre-Radiation Therapy of Head and Neck Cancer PatientsWithdrawnNCT04996641Not applicable
• STEP Together: An Effectiveness-Implementation Study of Social Incentives and Physical ActivityCompletedNCT04942535Not applicable
• OTL38 Injection (OTL38) for Intra-Operative Imaging of Folate Receptor Positive Ovarian CancerWithdrawnNCT04941378Phase 1
• Young Adults' Reactions to Low Nicotine Cigarette AdvertisingCompletedNCT04906148Not applicable
• CAR-T Followed by Bispecific AntibodiesActive, not recruitingNCT04889716Phase 2
• TACE Plus Axitinib and Hydroxychlorquine for Liver-Dominant Metastatic Colorectal Cancer (CRC)TerminatedNCT04873895Phase 1
• Telehealth Weight Loss Program for Breast Cancer SurvivorsActive, not recruitingNCT04855552Not applicable
• Abbreviate or FAST Breast MRI for Supplemental Breast Cancer Screening for Black Women at Average Risk and Dense BreastsActive, not recruitingNCT04854304
• Avelumab or Hydroxychloroquine With or Without Palbociclib to Eliminate Dormant Breast CancerActive, not recruitingNCT04841148Phase 2
• RADVAX™ for Relapsed/Refractory Non-Hodgkin Lymphoma: A Phase II Trial of Pembrolizumab + Low Dose RadiotherapyCompletedNCT04827862Phase 2
• Multimodality MRI and Liquid Biopsy in GBMWithdrawnNCT04776980Early Phase 1
• Effectiveness of MyCancerGene to Optimize Genetic Testing OutcomesActive, not recruitingNCT04774445Not applicable
• Shared Decision-making and Colorectal Cancer ScreeningCompletedNCT04748380Not applicable
• Choice Architecture and Mailed Colorectal Cancer Screening Outreach in a Community Health SettingCompletedNCT04711473Not applicable
• Functional Lung Imaging With DECT and 4DCTCompletedNCT04702607
• Cigar Packaging StudyCompletedNCT04605874Not applicable
• BAPS in Botswana: The Thotloetso TrialCompletedNCT04532970Not applicable
• BRCA1/2 Flu VaccineActive, not recruitingNCT04499534
• BreastVAX: Radiation Boost to Enhance Immune Checkpoint Blockade TherapyActive, not recruitingNCT04454528Phase 1/2
• Nivolumab + Ipilimumab With Immunostimulatory Embolization for Stage 4 Renal Cell Carcinoma With Unresected PrimaryTerminatedNCT04429321Phase 1
• Cardiotoxicity in Breast Cancer Patients Treated With Proton or Photon Radiotherapy: A RadComp Companion StudyCompletedNCT04361240
• Study of an eHealth Delivery Alternative for Cancer Genetic Testing for Hereditary Predisposition in Metastatic Cancer PatientsCompletedNCT04353973Not applicable
• Behavioral Relaxation Approaches for Insomnia in Lung Cancer PatientsWithdrawnNCT04318249Not applicable
• Cardiotoxicity in Locally Advanced Lung Cancer Patients Treated With Chemoradiation TherapyActive, not recruitingNCT04305613
• Penn Biobank Return of Research Results ProgramCompletedNCT04242667Not applicable
• Niraparib/TTFields in GBMActive, not recruitingNCT04221503Phase 2
• Optimizing Tobacco Use Treatment for PLWHAActive, not recruitingNCT04176172Phase 3
• MRI Effects of Pegvorhyaluronidase Alfa (PEGPH20) in Pancreatic Ductal AdenocarcinomaWithdrawnNCT04134468Phase 2
• Long Term Arrhythmia Risk and Cardiovascular Events in Hematopoietic Stem Cell TransplantCompletedNCT04118530
• Buddy Relationships in DermatoloGic Excisions for Skin CancerCompletedNCT04036344Not applicable
• Cardiovascular Effects of CART Cell TherapyCompletedNCT04026737
• Correlation of Early Postoperative Scar Appearance With Long-term Scar OutcomesCompletedNCT04015453
• Adjuvant Treatment Determined By Pathological Response To Neoadjvuant NivolumabActive, not recruitingNCT04013854Phase 2
• Evaluating an Alternative Clinical Genetics Cancer Care Deliver ModelCompletedNCT03934606
• Ostomy Rural Telehealth Training Cancer SurvivorsActive, not recruitingNCT03913715Not applicable
• Cigarette Packaging of Low Nicotine CigarettesCompletedNCT03802019Not applicable
• A Study of Entinostat and FOLFOX in Subjects With Pancreatic AdenocarcinomaWithdrawnNCT03760614Phase 1
• Cardiovascular Function in Acute LeukemiaCompletedNCT03760237
• Neoadjuvant PD-1 Blockade in Patients With Stage IIB/C MelanomaActive, not recruitingNCT03757689Phase 2
• TORS De-Intensification Protocol Version 2.0: Dose and Volume Reduction in the NeckCompletedNCT03729518Not applicable
• Yoga for Solid TumorWithdrawnNCT03728205Not applicable
• Young Adults and Low Nicotine CigarettesWithdrawnNCT03699865Not applicable
• HOPE: Olaparib, Palbociclib and Fulvestrant in Patients With BRCA Mutation-associated, HR+, HER2-metastatic Breast CancerCompletedNCT03685331Phase 1
• Lung Heart Rate VariabilityWithdrawnNCT03674450Not applicable
• Ipilumumab and Nivolumab With or Without Hypofractionated Radiotherapy in Patients With Metastatic MelanomaActive, not recruitingNCT03646617Phase 2
• A Prospective Study of Electronic Symptom Reporting Via Mobile Phone Among Patients With Advanced Non-Small Cell Lung CancerCompletedNCT03616522
• Pembrolizumab in Relapsed or Refractory Extranodal NK/T- Cell Lymphoma, Nasal Type and EBV-associated Diffuse Large B Cell LymphomasWithdrawnNCT03586024Phase 1/2
• Pilot Study of 18F-FMISO PET/CT and MRI Imaging to Explore Tissue Hypoxia and Arteriovenous Shunting in Subjects With Recurrent Glioblastoma Before and After Bevacizumab TreatmentTerminatedNCT03573986Phase 1
• Pilot Cohort Study of Rb-82 Myocardial PET Imaging to Evaluate Coronary Microvascular Dysfunction in Men With Prostate Cancer Receiving Androgen-Deprivation TherapyCompletedNCT03535987
• Genetics and Heart Health After Cancer TherapyCompletedNCT03510689
• In Vivo PARP-1 Expression With 18F-FTT PET/CT in Pancreatic CancerTerminatedNCT03492164Early Phase 1
• Avelumab/Gemcitabine in Sarcomatoid RCCTerminatedNCT03483883Phase 1
• Personalized Radiation Therapy for GBMCompletedNCT03477513Not applicable
• A Randomized Study to Establish the Efficacy of Oral Ice Exposure During Oxaliplatin Infusion in Preventing Oral Cold SensitivityTerminatedNCT03427021Early Phase 1
• Gedatolisib, Hydroxychloroquine or the Combination for Prevention of Recurrent Breast Cancer ("GLACIER")WithdrawnNCT03400254Phase 1/2
• AYA STEPS RCT: AYA Self-Management Via Texting, Education & Plans for SurvivorsActive, not recruitingNCT03363711
• Evaluating in Vivo PARP-1 Expression With 18F-FluorThanatrace Positron Emission Tomography (PET/CT) in Prostate CancerActive, not recruitingNCT03334500Early Phase 1
• A Phase Ib Pharmacodynamic Study of Neoadjuvant Paricalcitol in Resectable Pancreatic Cancer A Phase Ib Pharmacodynamic Study of Neoadjuvant Paricalcitol in Resectable Pancreatic CancerTerminatedNCT03300921Phase 1
• Pilot Study of Blinatumomab in Combination With Salvage Autologous Stem Cell Transplantation for Patients With Refractory Multiple MyelomaTerminatedNCT03173430Early Phase 1
• RCT of ACP for TransplantWithdrawnNCT03158467
• A PHASE I, SINGLE-CENTER, MIXED METHODS STUDY ON THE HEALTH OUTCOMES OF VISUAL SELF EXPRESSIONCompletedNCT03155672
• A PILOT STUDY OF DIFFUSION WEIGHTED MRI TO ASSESS ESOPHAGEAL TUMOR RESONSE TO NEOADJUVANT CHEMORADIATIONCompletedNCT03151642
• Evaluating in Vivo PARP-1 Expression With 18F-FluorThanatrace Positron Emission Tomography (PET/CT) in Breast CancerActive, not recruitingNCT03083288Phase 1
• Early FDG PET/CT Imaging as a Measure of Response in Patients With Non-Hodgkin Lymphoma on LenalidomideTerminatedNCT03065790
• Imaging of in Vivo Sigma-2 Receptor Expression With 18F-ISO-1 Positron Emission Tomography in Metastatic Breast CancerTerminatedNCT03057743
• A Pilot Study to Develop Predictive Biomarkers for the Response to Immunotherapy in Lung CancerCompletedNCT03047616
• Clonal Evolution of B Cells in High-risk CLL After Idelalisib-rituximabWithdrawnNCT02993536
• Circulating Tumor Material in Colorectal Cancer and MelanomaCompletedNCT02907086
• Galunisertib (LY2157299) Plus Stereotactic Body Radiotherapy (SBRT) in Advanced Hepatocellular Carcinoma (HCC)CompletedNCT02906397Phase 1
• RADVAX™: A Trial of Combined Pembrolizumab and Hypofractionated Radiation in Patients With Advanced Urothelial Cancer Who Have Progressed on Anti-PD-1/PD-L1 MonotherapyWithdrawnNCT02880345Phase 1
• Surveillance Markers of Utility for Recurrence After Neoadjuvant Chemotherapy for Breast CancerCompletedNCT02830282

← Abramson Cancer Center at Penn Medicine overview and focus areas